📰 Trappsol Cyclo News
Page 2 - Trappsol Cyclo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trappsol Cyclo. Real-time updates on events, politics, business and more.
February 4, 2024
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report)’s stock price fell 1.1% during mid-day trading on Friday . The stock traded as low as $1.81 and last traded at $1.88. 26,821 shares changed hands during trading, a decline of 76% from the average session volume of 111,431 shares. The stock had previously closed at $1.90. […]
January 31, 2024
Argenx (NASDAQ:ARGX – Get Free Report) and Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Institutional & Insider Ownership 52.8% of argenx shares are […]
January 29, 2024
(RTTNews) - Cyclo Therapeutics, Inc. (CYTH), a clinical-stage biotechnology company, announced on Monday that it has received a Notice of Allowanc...
January 12, 2024
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 331,200 shares, an increase of 83.3% from the December 15th total of 180,700 shares. Currently, 3.1% of the company’s stock are short sold. […]
November 29, 2023
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 223,000 shares, an increase of 76.4% from the October 31st total of 126,400 shares. Currently, 2.6% of the company’s shares are sold short. Based on an average daily trading […]
October 1, 2023
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 133,100 shares, a decrease of 31.3% from the August 31st total of 193,800 shares. Based on an average daily volume of 56,400 shares, the short-interest ratio […]
August 26, 2023
Axcella Health (NASDAQ:AXLA – Get Free Report) and Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings. Earnings & Valuation This table compares Axcella […]
August 26, 2023
Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) and Axcella Health (NASDAQ:AXLA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, risk, earnings and valuation. Earnings & Valuation This table compares Cyclo […]
August 3, 2023
The Dow Jones closed lower by around 350 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
July 30, 2023
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 94,400 shares, an increase of 93.8% from the June 30th total of 48,700 shares. Based on an average daily trading volume, of 153,200 […]